Revised forecast
Fiscal year ending August 2026 · Full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
The timing of revenue recognition for some large domestic projects was pushed back to the following fiscal year or later, gross profit declined due to lower net sales, expenses increased as a result of R&D investment and the strengthening of the R&D structure, and an impairment loss on investment securities was recorded.
Impairment loss on investment securities: ¥101 million
| Item | Details |
|---|---|
| Net Sales | △153 |
| Operating profit | △71 |
| Ordinary income | △28 |
| Profit attributable to owners of the parent | △124 |
| Fiscal Period Covered | Fiscal year ending August 2026 |
| Period Covered | Full year |
| Previous-period results | Net sales: ¥1,615 million; operating income: ¥15 million; ordinary loss: ¥198 million; net loss for the period: ¥210 million; loss per share: ¥28.24 |
| Reason for the revision | The timing of revenue recognition for some large domestic projects was pushed back to the following fiscal year or later, gross profit declined due to lower net sales, expenses increased as a result of R&D investment and the strengthening of the R&D structure, and an impairment loss on investment securities was recorded. |
| Details and amount of extraordinary loss | Impairment loss on investment securities: ¥101 million |
| Consolidated / non-consolidated | Non-consolidated |
Items this document does not state (3)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The reasons were that the timing of revenue recognition for some large domestic projects was pushed back to the following fiscal year or later, gross profit declined due to lower net sales, and expenses increased as a result of R&D investment and the strengthening of the R&D structure to support future business expansion. In addition, net loss for the period widened because an impairment loss on investment securities of ¥101 million was recorded as an extraordinary loss.